Schonfeld Strategic Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Sell |
|
|||||
|
2025
Q1 | $1.45M | Sell |
|
|||||
|
2024
Q4 | $2.02M | Buy |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $371K | Buy |
|
|||||
|
2024
Q1 | $334K | Sell |
|
|||||
|
2023
Q4 | $466K | Buy |
|
|||||
|
2023
Q3 | $294K | Sell |
|
|||||
|
2023
Q2 | $7.67M | Buy |
|
|||||
|
2023
Q1 | $1.84M | Sell |
|
|||||
|
2022
Q4 | $8.43M | Buy |
|
|||||
|
2022
Q3 | $876K | Sell |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $2.97M | Buy |
|
|||||
|
2021
Q4 | $2.44M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $362K | Sell |
|
|||||
|
2021
Q1 | $4.63M | Buy |
|
|||||
|
2020
Q4 | $1.25M | Sell |
|
|||||
|
2020
Q3 | $1.36M | Buy |
|